Fauna Bio is an AI-driven drug discovery company developing therapeutics inspired by natural disease resistance in mammals. The company studies species that have evolved extraordinary resilience to physiological stress, including hibernation, metabolic suppression, tissue injury, muscle loss, fibrosis, hypoxia, and organ damage. Fauna Bio combines proprietary cross-species omics datasets with its Convergence platform to identify conserved protective pathways, prioritize novel drug targets, and rapidly validate therapeutic hypotheses in disease-relevant models.